CD40LG and rheumatoid arthritis: Among several autoantibodies described in recent years in patients with RA [20,23,25,28], synthetic cyclic peptides containing citrulline CCP antibodies has been proposed as a new biomarker of disease severity, since it has been found to be more sensitive than the IgM-RF by all who have published studies on this area.